What is Quality Medical Research?
Quality Medical Research is a clinical research center in the Nashville metro area, committed to advancing healthcare through innovative studies and providing access to affordable treatments and medications for diverse communities.
Clinical Trials
Explore the forefront of medical innovation with Quality Medical Research’s Clinical Trials section. Engage in cutting-edge research opportunities aimed at advancing digestive health treatments. Join our pioneering efforts in shaping the future of gastroenterology care.
Research News and Media
Stay informed with the latest developments in digestive health through Quality Medical Research’s Research News and Media section. Discover insightful articles, informative videos, and breaking news covering the forefront of gastroenterology research. Empower yourself with knowledge to make informed decisions about your health.
FDA approves niraparib and abiraterone acetate plus prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer
Read Original Article →FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
Read Original Article →FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations
Read Original Article →FDA approves amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications
Read Original Article →FDA approves atezolizumab and hyaluronidase-tqjs for subcutaneous injection
Read Original Article →FDA approves axatilimab-csfr for chronic graft-versus-host disease
Read Original Article →FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma
Read Original Article →FDA approves durvalumab for limited-stage small cell lung cancer
Read Original Article →FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
Read Original Article →FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma
Read Original Article →FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer
Read Original Article →FDA approves inotuzumab ozogamicin for pediatric patients with acute lymphoblastic leukemia
Read Original Article →FDA approves irinotecan liposome for first-line treatment of metastatic pancreatic adenocarcinoma
Read Original Article →FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma
Read Original Article →FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer
Read Original Article →FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS
Read Original Article →FDA approves amivantamab and hyaluronidase-lpuj for subcutaneous injection
Read Original Article →FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma
Read Original Article →Drug Therapies and Incidence of Dementia Among Adults With Overactive Bladder
Read Original Article →Teacher Professional Development and Wellness Program in Primary Schools
Read Original Article →Durability of Immunity and Safety of RSV Vaccination in High-Risk Transplant Recipients
Read Original Article →Biologics Electronic Reading Room (eFOIA)
Read Original Article →OTP Guidance Webinar: Potency Assurance for Cellular and Gene Therapy Products - 12/10/2026
Read Original Article →Delivering Answers and Hope for Rare Disease Families
Read Original Article →Error in Hemoglobin Concentration
Read Original Article →FDA Expedited Investigational New Drug (IND) Pilot Program
Read Original Article →Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus
Read Original Article →Workshop on Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors - 11/14/2024
Read Original Article →Office of Therapeutic Products (OTP) Events, Meetings, and Workshops
Read Original Article →Body Mass Index, Genetic Predisposition, and Obesity-Related Second Cancer Risk
Read Original Article →Perinatal Digital Intervention to Prevent Increasing Anxiety
Read Original Article →Telemedicine and Cardiac Service Utilization After the COVID-19 Pandemic
Read Original Article →Generative AI and Maternal Health Outcomes in Pregnant and Postpartum Individuals
Read Original Article →Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence
Read Original Article →Adoption of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postpartum Infections
Read Original Article →Tenecteplase Before Thrombectomy for Basilar Artery Occlusion
Read Original Article →Spousal TBI and Risk of Mortality, Dementia, and Cardiovascular Events
Read Original Article →GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity
Read Original Article →Early Metformin Initiation and Glycemic Outcomes in Gestational Diabetes
Read Original Article →Public Data on Medications for Opioid Use Disorder in US Jails and Prisons
Read Original Article →National Trends in Severe Maternal Morbidity by Insurance and Race and Ethnicity
Read Original Article →Accelerated Approvals and Clinical Evidence for Medications for Children
Read Original Article →Full-Service Mobile Food Markets and Dietary Quality in Low-Income Housing
Read Original Article →Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
Read Original Article →Early Alert: Transcatheter Mitral Valve Delivery System Issue from Edwards Lifesciences
Read Original Article →
We talk about a clinical trial for a new treatment for NASH (non-alcoholic steatohepatitis). The goal...
We talk about fatty liver disease, which is the buildup of fat in the liver. NASH is a more serious condition...
See what drives the passion for companies like QMR on Advancements with Ted Danson: Spotlight on Clinical...
Feel free to contact us to learn more.
Contact Us
(615) 835-4720
studies@thegidocs.com
Address
330 Wallace Road Suite 103 Nashville, TN 37211
Patient Resources
Empower yourself with valuable patient resources designed to support your digestive health journey at Quality Medical Research and Digestive & Liver Health Specialists.
